Genmab reported 174.28B in Market Capitalization this October of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 1.22B 0.38B
Almirall ALM:SM 1.92B 152.39M
Amarin AMRN:US 0.59B 0.71B
Amgen AMGN:US $ 129.97B 0.89B
Argen X Bv ARGX:BB 19.17B 4.02B
Artemis Alpha ATS:LN 13.9B 3B
AstraZeneca AZN:LN 16734.4B 1035.33B
Bayer BAYN:GR 55.72B 5.79B
Biomarin Pharmaceutical BMRN:US $ 15.33B 1.08B
Bluebird Bio BLUE:US $ 0.3B 0.05B
Exelixis EXEL:US $ 6.68B 0.58B
Fresenius Medical Care FME:GR 13.98B 3.83B
Galapagos GLPG:NA 3.49B 209.75M
Genmab GEN:DC 151.04B 11B
GlaxoSmithKline GSK:LN 8976.58B 602.38B
GN Store Nord GN:DC 34.12B 11.85B
Hikma Pharmaceutical HIK:LN 356.03B 157.67B
Immunogen IMGN:US $ 0.99B 0.06B
Insmed INSM:US $ 2.36B 0.43B
Lonza Group LONN:SW 37.9B 18.81B
Merck MRK:GR 20.81B 3.73B
Novartis NOVN:VX 194.34B 3.46B
Regeneron Pharmaceuticals REGN:US $ 64.93B 10.87B
Roche Holding ROG:VX 300.5B 1.25B
Sanofi SAN:FP 121.89B 4.99B
Seattle Genetics SGEN:US $ 32.57B 6.12B
UCB UCB:BB 15.68B 3.83B
William Demant Holding WDH:DC 61.07B 19.4B